Home / Markets / Industries / Health Care
Monday, November 16, 2009
Abbott Laboratories Reports Positive Results on Niaspan
FOXBusiness
Abbott Laboratories (ABT) announced on Monday positive results of cholesterol drug Niaspan. The company said that patients who used Niaspan along with a statin had improvement in clogged arteries after 8 to 14 months.
The Arbiter 6 study, which was funded by Abbot, was conducted on 208 patients. Those patients also reported fewer major cardiac events, like heart attacks. The patients tested were at high risk for heart attack and were already taking statins to lower cholesterol.
Fox Business Video
-
-
Don’t Sweat Party Cleanup
-
Feb 9, 2010
Start-up Challenge
-
-
-
Obama’s Stance on Offshore D...
-
Feb 9, 2010
Street Meat
-
-
-
Who Will Make the Next Run on ...
-
Feb 9, 2010
Trading Places
-
-
-
Solving the Jobless Situation
-
Feb 9, 2010
Diamond District
-
-
-
Cavuto Business Report: 02-09-10
-
Feb 9, 2010
Business Report: Cavuto
-
Last 5 Stocks
- Ticker
- Company
- Price
- Change